At least for the short term this is more than lift

At least for the short term this is more than lifting the hold and resuming R&D. The FDA is lending some validity to the Cytodyn brand after years of perceived illegitimacy. Of course it is up to Dr. Jay and the entire team to see that validity and relevance continue long term.